Related Experiment Video
Updated: Jun 1, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Temporal bone histopathology in neurofibromatosis type 2
Sung-Il Nam1, Fred H Linthicum, Saumil N Merchant
1Massachusetts Eye and Ear Infirmary and Harvard Medical School, Boston, Massachusetts 02114-3006, USA.
The Laryngoscope
|June 15, 2011
Summary
Neurofibromatosis type 2 (NF2) causes aggressive, multicentric cochleovestibular schwannomas that invade the labyrinth. These tumors often lead to cochlear degeneration, complicating surgical removal and hearing preservation.
Area of Science:
- Otopathology
- Neuro-oncology
- Genetics
Background:
- Limited data exists on the temporal bone histopathology in neurofibromatosis type 2 (NF2).
- Understanding NF2-related temporal bone pathology is crucial for managing hearing loss and surgical outcomes.
Purpose of the Study:
- To elucidate the histopathologic features of temporal bones in patients diagnosed with NF2.
- To provide detailed insights into the otopathology associated with NF2.
Main Methods:
- A basic science study involving light microscopy of 26 temporal bones from 16 NF2 patients.
- NF2 diagnosis confirmed by bilateral cochleovestibular schwannomas; clinical data reviewed.
Main Results:
- Tumors were multicentric in 73% of ears, originating in the internal auditory canal and labyrinth.
- High cellularity, labyrinthine involvement, and cochlear sensory/neural degeneration were common.
- Facial nerve involvement by schwannoma occurred in 58% of ears; fusion tumors were observed.
Conclusions:
- Cochleovestibular schwannomas in NF2 are aggressive, multicentric neoplasms with labyrinthine propensity.
- Secondary cochlear degeneration is frequent, increasing surgical complexity and hindering hearing preservation.
- These findings highlight challenges in complete tumor removal while preserving hearing compared to sporadic schwannomas.
